Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017
Saccades in Presymptomatic and Early Stages of Huntington Disease
Neurol 67:394-399, Blekher,T.,et al, 2006
Identification of an Oculomotor biomarker of Preclinical Huntington Disease
Neurol 67:485-487, Golding,C.V.P.,et al, 2006
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Novel Brainstem Syndrome Associated with Prostate Carcinoma
Neurol 43:2591-2596, Baloh,R.W.,et al, 1993
Ocular Myasthenia Gravis
J Natl Med Assoc 85:681-684, March,G.A.&Johnson,J.N., 1993
Oculomotor, Auditory, and Vestib ular Responses in Myotonic Dystrophy
Arch Neurol 49:954-960, Verhagen,W.I.M.,et al, 1992
Paralysis of Saccades and Pursuit:Clinicopath Study
Neurol 41:414-415, Dehaene,I.&Lammens,M., 1991
Effects of Induced Hyperthermia on Visual Evoked Potentials & Saccade Parameters in Normal Subjects & MS Pts
JNNP 43:849-852, Bajada,S.,et al, 1980
Effect of Aging on Eye Tracking
Arch Neurol 37:575-576, Spooner,J.W.,et al, 1980
Subclinical Eye Movement Disorders in Patients with Multiple Sclerosis
Neurol 27:614, Solingen,L.D.,et al, 1977